Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Substituted piperazines as KRAS G12C inhibitors

US Patent 11285156 · Granted Mar 29, 2022

Estimated economic value: $231,793,000

Assignee

Inventors

View full patent text on Google Patents →